secwatch.observer — SEC 8-K summary
======================================

Issuer:     DermTech, Inc. (—)
CIK:        0001651944
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001651944-23-000060
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DermTech shareholders approve doubling authorized shares and expanding equity incentive plan
--------------------------------------------------------------------------------

- Authorized common stock increased from 50M to 100M shares; approved by 20.6M votes for, 2.3M against.
- 2020 equity plan evergreen raised from 3.5% to 5% of outstanding shares annually, extended through FY2030.
- Nathalie Gerschtein Keraudy elected as Class III director until 2026; board size reduced to seven.
- Proposal to add officer exculpation under Delaware law failed; KPMG LLP ratified as auditor.
- Plan amendment allows up to 75M shares for ISOs; aggregate grant cap for non-employee directors set at $600K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/0001651944-23-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651944/000165194423000060/dmtk-20230531.htm
  HTML page:      https://secwatch.observer/filing/0001651944-23-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer